Primary Open Angle Glaucoma (POGA) Market to Expand at an Immense Growth Rate During the Forecast Period (2019-32) - Asserts DelveInsight | Key Companies - Laboratorios Sophia, Aerie Pharma, Santen Pharma, MediPrint Ophthalmics, Aerpio Therapeutics, Occul

DelveInsight's "Primary Open Angle Glaucoma (POGA) Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Primary Open Angle Glaucoma Market Size and Share in the 7MM (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Primary Open Angle Glaucoma market report covers emerging drugs, treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Primary Open Angle Glaucoma: An Overview
Glaucoma is a group of conditions in which there is characteristic cupping of the optic disc with corresponding visual field defects, due to retinal ganglion cell loss. It is one of the most common causes of irreversible blindness worldwide. The two major categories of glaucoma are open-angle glaucoma (OAG) and narrow-angle glaucoma. The OAG is primarily divided into two subtypes, i.e., Primary open-angle glaucoma (POAG) and Secondary open-angle glaucoma. It is observed that Primary OAG accounts for 90% of open-angle Glaucoma cases

Primary open-angle glaucoma (POGA) is a syndrome of optic nerve damage associated with an open anterior chamber angle and an elevated or sometimes average intraocular pressure (IOP). POAG is caused by the slow clogging of the drainage canals, resulting in increased IOP. It has a wide and open angle between the iris and cornea.

Primary Open Angle Glaucoma Market Key Facts
As per DelveInsight, in 2020, the total prevalent population of Glaucoma in the US was estimated to be 3,210,300+. In 2020, there were 2,967,468 cases of OAG in the US.
Among the 7MM, the most diagnosed prevalent cases of POAG were recorded in the United States, while the lowest prevalent population of POAG was recorded in Spain.
Among the EU5 countries, Germany has the highest diagnosed prevalent population of POAG, followed by Italy.
The total diagnosed prevalent population of POAG in the US was assessed to be 2,670,700+ in 2020.

Find a sample copy of the Primary Open Angle Glaucoma Market report at:
https://www.delveinsight.com/sample-request/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Primary Open Angle Glaucoma Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Primary Open Angle Glaucoma market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Primary Open Angle Glaucoma market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request a sample and discover more about the report offerings @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Primary Open Angle Glaucoma Epidemiology
The epidemiology section covers detailed insights into the historical and current Primary Open Angle Glaucoma patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032.

Explore more about the Primary Open Angle Glaucoma Epidemiology @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Primary Open Angle Glaucoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Primary Open Angle Glaucoma market or expected to get launched in the market during the study period. The analysis covers Primary Open Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Primary Open Angle Glaucoma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for a sample report to understand more about the Primary Open Angle Glaucoma pipeline development activities @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Primary Open Angle Glaucoma Therapeutics Assessment
Globally, there are approx. 10+ key companies which are developing the therapies for Primary Open Angle Glaucoma (POAG). The companies which have their Primary Open Angle Glaucoma (POAG) drug candidates in the most advanced stage, i.e. phase III include Laboratorios Sophia S.A de C.V.

Some of the key companies in the Primary Open Angle Glaucoma Therapeutics Market include Laboratorios Sophia S.A de C.V., Aerie Pharmaceuticals, Santen Pharmaceuticals, Chong Kun Dang Pharmaceutical, MediPrint Ophthalmics, Inc., Aerpio Therapeutics, Whitecap Biosciences, LLC, Occular Therapeutics, and Others.

Primary Open Angle Glaucoma Therapies covered in the report include PRO-122, DE-126, and Others.

Learn more about the emerging therapies & key companies in the Primary Open Angle Glaucoma Therapeutics Market @
https://www.delveinsight.com/report-store/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Primary Open Angle Glaucoma Report Key Insights
1. Primary Open Angle Glaucoma Patient Population
2. Primary Open Angle Glaucoma Market Size and Trends
3. Key Cross Competition in the Primary Open Angle Glaucoma Market
4. Primary Open Angle Glaucoma Market Dynamics (Key Drivers and Barriers)
5. Primary Open Angle Glaucoma Market Opportunities
6. Primary Open Angle Glaucoma Therapeutic Approaches
7. Primary Open Angle Glaucoma Pipeline Analysis
8. Primary Open Angle Glaucoma Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Primary Open Angle Glaucoma Market

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Primary Open Angle Glaucoma Competitive Intelligence Analysis
4. Primary Open Angle Glaucoma Market Overview at a Glance
5. Primary Open Angle Glaucoma Disease Background and Overview
6. Primary Open Angle Glaucoma Patient Journey
7. Primary Open Angle Glaucoma Epidemiology and Patient Population
8. Primary Open Angle Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Primary Open Angle Glaucoma Unmet Needs
10. Key Endpoints of Primary Open Angle Glaucoma Treatment
11. Primary Open Angle Glaucoma Marketed Products
12. Primary Open Angle Glaucoma Emerging Therapies
13. Primary Open Angle Glaucoma Seven Major Market Analysis
14. Attribute Analysis
15. Primary Open Angle Glaucoma Market Outlook (7 major markets)
16. Primary Open Angle Glaucoma Access and Reimbursement Overview
17. KOL Views on the Primary Open Angle Glaucoma Market.
18. Primary Open Angle Glaucoma Market Drivers
19. Primary Open Angle Glaucoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

Get the Detailed TOC of the Primary Open Angle Glaucoma Market report here:
https://www.delveinsight.com/sample-request/primary-open-angle-glaucoma-poag-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187
www.delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.

This release was published on openPR.